Section one: Contracting authority
one.1) Name and addresses
NHS BLMK Clinical Commissioning Group
Capability House
Silsoe, Bedfordshire
MK45 4HR
Contact
Samuel Naxton
Country
United Kingdom
NUTS code
UKH24 - Bedford
Internet address(es)
Main address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Community Lipid Management Service
Reference number
ACE-0490-2021-BLMK
two.1.2) Main CPV code
- 85100000 - Health services
two.1.3) Type of contract
Services
two.1.4) Short description
NHS BLMK Clinical Commissioning Group has awarded a contract to Evexia Health Ltd following an 'Open' procurement process to deliver a new Community Lipid Management Service.
The purpose of the Community Lipid Service is to provide a consistent, evidence-based approach to lipid management across BLMK CCG. The Community Lipid Clinic will form part of a new pathway developed with key stakeholders across BLMK, in line with evidenced-based best practice. The service will be funded to provide clinical activity to optimise lipid management in populations at very high risk of CVD (as defined by the commissioner) and provide clinical assessment for familial hypercholesterolemia in people meeting appropriate clinical criteria (as defined by the commissioner), in line with locally developed evidence-based pathways. The Community Lipid Clinic will accept referrals of people meeting the relevant clinical criteria who are registered with a GP practice in Bedfordshire, Luton and Milton Keynes Integrated Care System.
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £200,000
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKH24 - Bedford
Main site or place of performance
Bedfordshire, Luton and Milton Keynes
two.2.4) Description of the procurement
NHS BLMK CCG secured Pathway Transformation Funding (PTF) to support the adoption of a new lipid management pathway and the establishment of community lipid services. The Community Lipid service will offer:
• A full assessment of people referred with CVD and/or FH and also uncontrolled hypercholesterolaemia or mixed dyslipidemia, including review of current and previous lipid lowering treatments, adherence with treatment regimes and any reasons for discontinuation.
• Pharmacological management and monitoring of effectiveness and tolerability in line with pathways agreed with the commissioner.
• Requesting of appropriate pathology tests at appropriate intervals through the relevant pathology system.
• Electronic prescription of relevant medications, in sufficient quantity to meet the requirements for uptitration between review contacts.
• Comprehensive documentation of each clinical contact in the shared clinical record on SystmOne.
• Support for self-management and education on the significance of managing cardiovascular risk factors, including cholesterol.
• Appropriate signposting to other services to support optimisation of health and wellbeing, including weight management, smoking cessation, alcohol support and talking therapies.
• Onward referral to specialist lipid services of patients with uncontrolled lipids despite maximum tolerated oral therapy, in line with criteria and pathways agreed with the commissioner.
• Clinical assessment of people with clinical features suggestive of suspected FH (as defined by the commissioner), with onward referral as appropriate to specialist lipid services.
• Clear treatment plans with appropriate patient-driven uptitration of therapy, timing of repeat lipid testing and scheduling of follow-up to allow maximal impact from each clinical contact.
two.2.5) Award criteria
Quality criterion - Name: Quality / Weighting: 100%
Price - Weighting: 0%
two.2.11) Information about options
Options: Yes
Description of options
Contract duration is for 12 months (01st January 2022 to 31st December 2022) with an option to extend for a further 12 months subject to funding, learning and benefits outcomes.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2021/S 000-018335
Section five. Award of contract
Contract No
M1J4AY Community Lipid Service 2021-22
Title
Community Lipid Service
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
27 October 2021
five.2.2) Information about tenders
Number of tenders received: 2
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Evexia Health Ltd
2a Malzeard Road
Luton
LU3 1BD
Country
United Kingdom
NUTS code
- UKH21 - Luton
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Total value of the contract/lot: £200,000
Section six. Complementary information
six.3) Additional information
Contract Duration:
12 months with an option to extend for a further 12 months subject to funding, learning and benefits outcomes.
Contract Value:
£100,000 per annum
Total contract value for a 24 month period:
£200,000
six.4) Procedures for review
six.4.1) Review body
High Court of Justice of England and Wales
Strand
London
WC2A 2LL
Country
United Kingdom